Symptom‐based staging for logopenic variant primary progressive aphasia

Chris J. D. Hardy,Cathleen Taylor‐Rubin,Beatrice Taylor,Emma Harding,Aida Suarez Gonzalez,Jessica Jiang,Laura Thompson,Rachel Kingma,Anthipa Chokesuwattanaskul,Ffion Walker,Suzie Barker,Emilie Brotherhood,Claire Waddington,Olivia Wood,Nikki Zimmermann,Nuriye Kupeli,Keir X. X. Yong,Paul M. Camic,Joshua Stott,Charles R. Marshall,Neil P. Oxtoby,Jonathan D. Rohrer,Frankie O'Shea,Anna Volkmer,Sebastian J. Crutch,Jason D. Warren
DOI: https://doi.org/10.1111/ene.16304
2024-04-28
European Journal of Neurology
Abstract:Background and purpose Logopenic variant primary progressive aphasia (lvPPA) is a major variant presentation of Alzheimer's disease (AD) that signals the importance of communication dysfunction across AD phenotypes. A clinical staging system is lacking for the evolution of AD‐associated communication difficulties that could guide diagnosis and care planning. Our aim was to create a symptom‐based staging scheme for lvPPA, identifying functional milestones relevant to the broader AD spectrum. Methods An international lvPPA caregiver cohort was surveyed on symptom development under an 'exploratory' survey (34 UK caregivers). Feedback from this survey informed the development of a 'consolidation' survey (27 UK, 10 Australian caregivers) in which caregivers were presented with six provisional clinical stages and feedback was analysed using a mixed‐methods approach. Results Six clinical stages were endorsed. Early symptoms included word‐finding difficulty, with loss of message comprehension and speech intelligibility signalling later‐stage progression. Additionally, problems with hearing in noise, memory and route‐finding were prominent early non‐verbal symptoms. 'Milestone' symptoms were identified that anticipate daily‐life functional transitions and care needs. Conclusions This work introduces a new symptom‐based staging scheme for lvPPA, and highlights milestone symptoms that could inform future clinical scales for anticipating and managing communication dysfunction across the AD spectrum.
neurosciences,clinical neurology
What problem does this paper attempt to address?